Fundz

Perceptive Capital to merge with Freenome Holdings

PUBLIC · FRNMDec 05, 2025

Acquiring Company

Freenome

Acquired Company

Freenome

BrisbaneBrisbaneBiotechnologyHealth CareScience And EngineeringVenture CapitalLife ScienceBiotechnologyHealth CareScience And EngineeringVenture CapitalLife Science

Description

Perceptive Capital Solutions Corp and Freenome Holdings, Inc. announced the effectiveness of their registration statement for a proposed business combination. The business combination is expected to close in July 2026, pending regulatory conditions. Following the merger, Perceptive Capital will be renamed Freenome, Inc.

Quick answer

Freenome is acquiring Freenome, announced December 5, 2025. Freenome is based in Brisbane, California, United States.

How much did Freenome pay for Freenome?
The deal value was not disclosed.
Where are Freenome and Freenome based?
Freenome is based in Brisbane, California, United States. Freenome is based in Brisbane, California, United States.
Who are the decision-makers at Freenome?
Fundz holds 1 contact at Freenome. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Science And Engineering and Venture Capital

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Freenome, and when

When Freenome changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Freenome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Freenome, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Freenome. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Freenome

Location

Brisbane, California, United States

About

Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. 1 Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC. Vital Signs: Colorectal Cancer Screening Test Use — United States, 2018. MMWR Morb Mortal Wkly Rep 2020;69:253–259. 2 United States Preventive Services Task Force (USPSTF), "Colorectal Cancer: Screening", May 18, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening SOURCE Freenome Holdings, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Freenome makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Brandon
Likely contact at this company
••••••••@••••••••

See Brandon's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Freenome's next move

Learn about Strategic plan

Frequently asked

Who acquired Freenome?

Freenome was acquired by Freenome, based in Brisbane. The deal was reported on December 5, 2025. Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw. Freenome is publicly traded (FRNM) and operates in Biotechnology.

When did Freenome acquire Freenome?

Freenome's acquisition of Freenome was reported on December 5, 2025. Perceptive Capital Solutions Corp and Freenome Holdings, Inc. announced the effectiveness of their registration statement for a proposed business combination. The business combination is expected to close in July 2026, pending regulatory conditions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Freenome do?

Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw. It is publicly traded (FRNM), operating in Biotechnology, and is based in Brisbane.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.